Arkansas · 64642

Injection Of Chemical For Paralysis Of Nerve Muscles On Arm Or Leg, 1-4 Muscles, First Extremity in Arkansas

Arkansas Medicare Avg
$69.81
26% below national avg
National Medicare Avg
$93.73
All states combined
Billed Charge (AR)
$374.54
What providers submit
Est. Commercial (AR)
$199.39
National avg: $277.64
Est. Cash / Self-Pay (AR)
$174.21
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

337
Services in AR
30
Providers
N/A
Min Payment
N/A
Max Payment

Top Providers in Arkansas

Provider Medicare Services
Gardner, Rani M.D. $70.77 28

Arkansas Pricing in Context

In Arkansas, CPT code 64642 (Injection Of Chemical For Paralysis Of Nerve Muscles On Arm Or Leg, 1-4 Muscles, First Extremity) carries an average Medicare payment of $69.81 — 26% below the national benchmark of $93.73. 30 providers across the state submitted claims for this procedure in 2023, performing 337 total services. Individual payments in AR ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in Arkansas is $374.54, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Arkansas sits below the national Medicare average, commercial rates in the state may also run lower than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Nervous System Surgery procedures, the estimated commercial insurance price in Arkansas lands near $199.39, with self-pay cash prices typically around $174.21. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Injection Of Chemical For Paralysis Of Nerve Muscles On Arm Or Leg, 1-4 Muscles, First Extremity cost in Arkansas?

The average Medicare payment for Injection Of Chemical For Paralysis Of Nerve Muscles On Arm Or Leg, 1-4 Muscles, First Extremity in Arkansas is $69.81, which is 26% below the national average of $93.73. Providers in AR typically bill $374.54 for this procedure.

What does Injection Of Chemical For Paralysis Of Nerve Muscles On Arm Or Leg, 1-4 Muscles, First Extremity cost with insurance in Arkansas?

With commercial insurance in Arkansas, Injection Of Chemical For Paralysis Of Nerve Muscles On Arm Or Leg, 1-4 Muscles, First Extremity costs an estimated $199.39. Without insurance, the estimated cash price is $174.21. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Injection Of Chemical For Paralysis Of Nerve Muscles On Arm Or Leg, 1-4 Muscles, First Extremity in Arkansas?

30 providers in Arkansas billed Medicare for Injection Of Chemical For Paralysis Of Nerve Muscles On Arm Or Leg, 1-4 Muscles, First Extremity in 2023, performing 337 total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Injection Of Chemical For Paralysis Of Nerve Muscles On Arm Or Leg, 1-4 Muscles, First Extremity cheaper in Arkansas than the national average?

Yes — Injection Of Chemical For Paralysis Of Nerve Muscles On Arm Or Leg, 1-4 Muscles, First Extremity costs 26% below the national average in Arkansas. The state average Medicare payment is $69.81 compared to $93.73 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial